Risk Management



Hemorrhage Associated with Ophthalmic Procedures

OMIC claims data indicates that ophthalmologists who do not properly screen patients for bleeding risks and manage hemorrhage when it occurs often face malpractice lawsuits. An OMIC closed case study of hemorrhage following blepharoplasty that resulted in a large settlement is presented to highlight errors in management that led to blindness and a subsequent lawsuit. Other parts of this article address how to screen patients for bleeding risk, monitor for hemorrhage, and begin to manage an orbital compartment syndrome.

We would like to thank OMIC Board member Dr. Ronald Pelton for his assistance with these documents.

OMIC risk management recommendations: Hemorrhage and Ophthalmic Procedures

Anticoagulant list

Anticoagulant form for patients

Anticoagulant consent form

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

61864684